Tamas Aranyi1, Katalin Susztak2. 1. Renal Electrolyte and Hypertension Division, Department of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, 12-123 Smilow Translational Research Building, Philadelphia, PA, 19104, USA. 2. Renal Electrolyte and Hypertension Division, Department of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, 12-123 Smilow Translational Research Building, Philadelphia, PA, 19104, USA. ksusztak@pennmedicine.upenn.edu.
Abstract
PURPOSE OF THE REVIEW: Kidney disease is the major cause of morbidity and mortality in patients with diabetes. Poor glycemic control shows the strongest correlation with diabetic kidney disease (DKD) development. A period of poor glycemia increases kidney disease risk even after an extended period of improved glucose control-a phenomenon called metabolic memory. Changes in the epigenome have been proposed to mediate the metabolic memory effect, as epigenome editing enzymes are regulated by substrates of intermediate metabolism and changes in the epigenome can be maintained after cell division. RECENT FINDINGS: Epigenome-wide association studies (EWAS) have reported differentially methylated cytosines in blood and kidney samples of DKD subjects when compared with controls. Differentially methylated cytosines were enriched on regulatory regions and some correlated with gene expression. Methylation changes predicted the speed of kidney function decline. Site-specific methylome editing tools now can be used to interrogate the functional role of differentially methylated regions. Methylome changes can be detected in blood and kidneys of patients with DKD. Methylation changes can predict future kidney function changes. Future studies shall determine their role in disease development.
PURPOSE OF THE REVIEW: Kidney disease is the major cause of morbidity and mortality in patients with diabetes. Poor glycemic control shows the strongest correlation with diabetic kidney disease (DKD) development. A period of poor glycemia increases kidney disease risk even after an extended period of improved glucose control-a phenomenon called metabolic memory. Changes in the epigenome have been proposed to mediate the metabolic memory effect, as epigenome editing enzymes are regulated by substrates of intermediate metabolism and changes in the epigenome can be maintained after cell division. RECENT FINDINGS: Epigenome-wide association studies (EWAS) have reported differentially methylated cytosines in blood and kidney samples of DKD subjects when compared with controls. Differentially methylated cytosines were enriched on regulatory regions and some correlated with gene expression. Methylation changes predicted the speed of kidney function decline. Site-specific methylome editing tools now can be used to interrogate the functional role of differentially methylated regions. Methylome changes can be detected in blood and kidneys of patients with DKD. Methylation changes can predict future kidney function changes. Future studies shall determine their role in disease development.
Authors: Mark Emmanuel Cooper; Assam El-Osta; Terri Jean Allen; Anna Margareta Dorothea Watson; Merlin Christopher Thomas; Karin Agnes Maria Jandeleit-Dahm Journal: Diabetes Date: 2018-05 Impact factor: 9.461
Authors: Christopher G Bell; Andrew E Teschendorff; Vardhman K Rakyan; Alexander P Maxwell; Stephan Beck; David A Savage Journal: BMC Med Genomics Date: 2010-08-05 Impact factor: 3.063
Authors: Caroline Gluck; Chengxiang Qiu; Sang Youb Han; Matthew Palmer; Jihwan Park; Yi-An Ko; Yuting Guan; Xin Sheng; Robert L Hanson; Jing Huang; Yong Chen; Ae Seo Deok Park; Maria Concepcion Izquierdo; Ioannis Mantzaris; Amit Verma; James Pullman; Hongzhe Li; Katalin Susztak Journal: Nat Commun Date: 2019-06-05 Impact factor: 14.919
Authors: Yi-An Ko; Davoud Mohtat; Masako Suzuki; Ae Seo Deok Park; Maria Concepcion Izquierdo; Sang Youb Han; Hyun Mi Kang; Han Si; Thomas Hostetter; James M Pullman; Melissa Fazzari; Amit Verma; Deyou Zheng; John M Greally; Katalin Susztak Journal: Genome Biol Date: 2013 Impact factor: 13.583
Authors: Chengxiang Qiu; Shizheng Huang; Jihwan Park; YoSon Park; Yi-An Ko; Matthew J Seasock; Joshua S Bryer; Xiang-Xi Xu; Wen-Chao Song; Matthew Palmer; Jon Hill; Paolo Guarnieri; Julie Hawkins; Carine M Boustany-Kari; Steven S Pullen; Christopher D Brown; Katalin Susztak Journal: Nat Med Date: 2018-10-01 Impact factor: 53.440
Authors: Laura J Smyth; Christopher C Patterson; Elizabeth J Swan; Alexander P Maxwell; Amy Jayne McKnight Journal: Front Cell Dev Biol Date: 2020-10-15